【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets/Categories Covered 14
3.1 In Vitro Diagnostics 14
3.1.1 Genetic Testing 14
3.1.2 Haematology 14
3.1.3 Immuno Chemistry 14
3.1.4 Infectious Immunology 14
3.1.5 Microbiology Culture 14
4 Company Snapshot 15
4.1 Key Information 15
4.2 Company Overview 15
4.3 Financial Performance 15
4.4 SWOT Snapshot 15
5 Business Description 16
5.1 Business Overview 16
5.2 Clinical Diagnostics 16
5.2.1 Overview 16
5.2.2 Financials 16
5.2.3 Capital Expenditure 16
5.2.4 Market View 16
5.3 Life Sciences 17
5.3.1 Overview 17
5.3.2 Financials 17
5.3.3 Capital Expenditure 17
5.3.4 Market View 17
5.4 Major Products and Services 17
5.4.1 Overview 17
6 History 18
7 Business Strategy 21
7.1 Mission Statement 21
8 SWOT Analysis 22
8.1 Overview 22
8.2 Bio-Rad Laboratories, Inc. Strengths 22
8.2.1 Diversified Segments Served 22
8.2.2 Global Presence 22
8.2.3 Product Development Efforts 23
8.3 Bio-Rad Laboratories, Inc. Weaknesses 23
8.3.1 Low Debt to Equity Ratio 23
8.3.2 Product Recalls 23
8.4 Bio-Rad Laboratories, Inc. Opportunities 23
8.4.1 Inorganic Growth Drivers 23
8.4.2 Rising Healthcare Expenditure in the US 24
8.4.3 Growth in Emerging Economies 24
8.4.4 Potential Life Sciences Market 24
8.5 Bio-Rad Laboratories, Inc. Threats 24
8.5.1 Intense Competition 24
8.5.2 Stringent Government Regulations 24
8.5.3 Changing Diagnostic Market Conditions 25
9 Competitors 26
10 Competitive Landscape 28
10.1 In Vitro Diagnostics (Genetic Testing), Global, Market Share (%), 2011 28
10.2 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Genetic Testing), by Region, Market Share (2011) 29
10.3 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Genetic Testing), by Country, Market Share (2011) 30
10.4 In Vitro Diagnostics (Haematology), Global, Market Share (%), 2011 32
10.5 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Haematology), by Region, Market Share (2011) 34
10.6 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Haematology), by Country, Market Share (2011) 35
10.7 In Vitro Diagnostics (Immuno Chemistry), Global, Market Share (%), 2011 37
10.8 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Immuno Chemistry), by Region, Market Share (2011) 39
10.9 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Immuno Chemistry), by Country, Market Share (2011) 40
10.10 In Vitro Diagnostics (Infectious Immunology), Global, Market Share (%), 2011 42
10.11 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Infectious Immunology), by Region, Market Share (2011) 44
10.12 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Infectious Immunology), by Country, Market Share (2011) 45
10.13 In Vitro Diagnostics (Microbiology Culture), Global, Market Share (%), 2011 47
10.14 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Microbiology Culture), by Region, Market Share (2011) 48
10.15 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Microbiology Culture), by Country, Market Share (2011) 49
11 Bio-Rad Laboratories, Inc. Medical Equipment Market Share Analysis 51
11.1 Bio-Rad Laboratories, Inc., In Vitro Diagnostics, Global, Category Revenue Share (2011) 51
11.2 Bio-Rad Laboratories, Inc., Asia-Pacific, Category Revenue Share (2011) 53
11.2.1 Bio-Rad Laboratories, Inc., Australia, Category Revenue Share (2011) 55
11.2.2 Bio-Rad Laboratories, Inc., China, Category Revenue Share (2011) 57
11.2.3 Bio-Rad Laboratories, Inc., India, Category Revenue Share (2011) 59
11.2.4 Bio-Rad Laboratories, Inc., Japan, Category Revenue Share (2011) 61
11.2.5 Bio-Rad Laboratories, Inc., Other Asia-Pacific, Category Revenue Share (2011) 63
11.3 Bio-Rad Laboratories, Inc., Europe, Category Revenue Share (2011) 65
11.3.1 Bio-Rad Laboratories, Inc., France, Category Revenue Share (2011) 67
11.3.2 Bio-Rad Laboratories, Inc., Germany, Category Revenue Share (2011) 69
11.3.3 Bio-Rad Laboratories, Inc., Italy, Category Revenue Share (2011) 71
11.3.4 Bio-Rad Laboratories, Inc., Spain, Category Revenue Share (2011) 73
11.3.5 Bio-Rad Laboratories, Inc., United Kingdom, Category Revenue Share (2011) 75
11.3.6 Bio-Rad Laboratories, Inc., Other Europe, Category Revenue Share (2011) 77
11.4 Bio-Rad Laboratories, Inc., Middle East and Africa, Category Revenue Share (2011) 79
11.5 Bio-Rad Laboratories, Inc., North America, Category Revenue Share (2011) 81
11.5.1 Bio-Rad Laboratories, Inc., Canada, Category Revenue Share (2011) 83
11.5.2 Bio-Rad Laboratories, Inc., United States, Category Revenue Share (2011) 85
11.6 Bio-Rad Laboratories, Inc., South and Central America, Category Revenue Share (2011) 87
11.6.1 Bio-Rad Laboratories, Inc., Brazil, Category Revenue Share (2011) 89
11.6.2 Bio-Rad Laboratories, Inc., Other South and Central America, Category Revenue Share (2011) 91
12 Share Holding Structure 93
13 Key Employees 94
14 Key Employee Biographies 95
15 Company Statement 96
16 Locations And Subsidiaries 97
16.1 Head Office 97
16.2 Other Locations & Subsidiaries 97
17 Financial Deals Landscape 100
17.1 Bio-Rad Laboratories, Inc., Deals Volume Summary, 2007 to YTD 2013 100
18 Bio-Rad Laboratories, Inc. Detailed Deal Summary 102
18.1 Asset Purchase 102
18.1.1 Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 102
18.2 Partnerships 103
18.2.1 Chembio Diagnostics Enters Into A Licensing Agreement With Bio-Rad Labs 103
18.2.2 Innogenetics Signs Licensing Agreement With Bio-Rad Labs 104
18.2.3 Bio-Rad Labs Enters Into An Agreement With Axis-Shield 105
18.2.4 Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 106
18.2.5 Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 107
18.2.6 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 108
18.2.7 Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 109
18.2.8 Axis-Shield Signs Option Agreement With Bio-Rad Labs 110
18.2.9 Ariana Pharma Enters Into Collaboration With Bio-Rad Labs, Inserm And Beaujon Hospital 111
18.2.10 Chembio Signs DPP Development Agreement With Bio-Rad Labs 112
18.2.11 Sysmex America Enters Into Co-Marketing Agreement With Bio-Rad Labs 113
18.2.12 Bio-Rad Extends Agreement With Beckman Coulter 114
18.2.13 Bio-Rad Labs Signs Co-Marketing Agreement With Siemens Medical 115
18.2.14 Bio-Rad Labs Completes Public Offering Of Senior Notes Due 2020 For $425 Million 116
18.2.15 Bio-Rad Labs Completes Private Placement Of 8% Senior Subordinated Notes For $300 Million 117
18.3 Acquisition 118
18.3.1 Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For $70 Million 118
18.3.2 Bio-Rad Labs Acquires QuantaLife For $162 Million 120
18.3.3 Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For $0.2 Million 121
18.3.4 Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For $3.4 Million 122
18.3.5 Bio-Rad Labs Acquires Diamed-France 123
18.3.6 Bio-Rad Labs Acquires Additional Stake In Diamed 124
18.3.7 Bio-Rad Labs Completes Acquisition Of Medical Diagnostics Segment From Biotest 125
18.3.8 Bio-Rad Labs Acquires Diamed 127
18.3.9 Bio-Rad Labs Acquires DiaMed Fennica And DiaMed (GB) 128
19 Recent Developments 129
19.1 Strategy And Business Planning 129
19.1.1 Aug 29, 2012: Bio-Rad Opens Digital Biology Center To Develop Products For R&D Markets Based On Its Droplet Digital Technology 129
19.2 Financial Announcements 129
19.2.1 Nov 06, 2012: Bio-Rad Reports Revenue Of $498.7m In Q3 2012 129
19.2.2 Aug 07, 2012: Bio-Rad Reports Revenue Of $510.4m In Q2 2012 130
19.2.3 May 02, 2012: Bio-Rad Reports Revenue Of $486.3m In Q1 2012 131
19.2.4 Feb 23, 2012: Bio-Rad Reports Revenue Of $2.1 Billion In 2011 131
19.2.5 Nov 01, 2011: Bio-Rad Reports Revenues Of $516.5m In Q3 2011 132
19.2.6 Aug 02, 2011: Bio-Rad Reports Revenue Of $521.7m In Q2 2011 133
19.2.7 May 03, 2011: Bio-Rad Reports Net Sales Of $485.1m In Q1 2011 134
19.2.8 Feb 24, 2011: Bio-Rad Reports Net Sales Of $1.9 Billion In 2010 134
19.2.9 Nov 02, 2010: Bio-Rad Reports Net Income Of $44.76 Million For Q3 2010 135
19.2.10 Aug 03, 2010: Bio-Rad Reports Net Income Of $37.95 Million In Q2 2010 136
19.2.11 May 04, 2010: Bio-Rad Reports Net Income Of $34.86 Million In Q1 2010 137
19.2.12 Feb 24, 2010: Bio-Rad Reports Net Income Of $144.6 Million In 2009 138
19.2.13 Nov 03, 2009: Bio-Rad Reports Net Income Of $38.5 Million In Q3 2009 139
19.2.14 Aug 04, 2009: Bio-Rad Reports Net Income Of $37.9 Million In Q2 2009 140
19.2.15 May 05, 2009: Bio-Rad Posts Net Income Of $30.3 Million In Q1 2009 141
19.2.16 Feb 26, 2009: Bio-Rad Posts Net Income Of $89.5 Million For 2008 141
19.2.17 Nov 06, 2008: Bio-Rad Reports 3Q 2008 Results 143
19.2.18 Aug 05, 2008: Bio-Rad Reports 2Q 2008 Results 144
19.2.19 May 06, 2008: Bio-Rad Reports Q1 2008 Results 145
19.2.20 Apr 11, 2008: Bio-Rad To Declare Q1 2008 Results 146
19.2.21 Feb 28, 2008: Bio-Rad Reports Q4 2007 Results 146
19.2.22 Nov 06, 2007: Bio-Rad Reports Q3 2007 Results 148
19.2.23 Oct 11, 2007: Bio-Rad To Announce Q3 2007 Results 149
19.2.24 Aug 07, 2007: Bio-Rad Reports Q2 2007 Results 149
19.2.25 May 03, 2007: Bio-Rad Reports Q1 2007 Results 150
19.2.26 Feb 22, 2007: Bio-Rad Reports Q4 2006 Results 151
19.3 Corporate Communications 152
19.3.1 Nov 01, 2011: Bio-Rad Appoints Deborah J Neff To Board 152
19.3.2 Mar 25, 2010: Bio-Rad Appoints Ted W. Love To Board 152
19.3.3 Oct 07, 2008: Bio-Rad Intent To List On The NYSE 153
19.3.4 Mar 05, 2007: Bio-Rad Announces AMEX Listing Compliance 153
19.3.5 Feb 20, 2007: Bio-Rad Appoints New Board Member 153
19.4 Legal and Regulatory 154
19.4.1 Apr 30, 2012: Vermillion Resolves Non-Contingent Claims With Bio-Rad 154
19.4.2 Aug 13, 2011: GE Healthcare And Bio-Rad Reach Settlement In Label-Free Detection Lawsuit 154
19.5 Product News 155
19.5.1 Jul 25, 2011: Bio-Rad Receives FDA Premarket Application Approval For GS HIV Combo Ag/Ab EIA 155
19.5.2 May 17, 2011: Bio-Rad Launches Antiphospholipid Syndrome IgG, IgM, And IgA Kits For BioPlex 2200 System 155
19.5.3 Apr 20, 2011: Researchers Use Bio-Rad’s ProteoMiner Technology To Profile Relative Protein Abundance And Identify Post-Translationally Modified Proteins In Human Saliva 156
19.5.4 Oct 13, 2010: Bio-Rad And Axis-Shield Announce FDA Clearance And US Launch Of Anti-CCP Test For Rheumatoid Arthritis For Bio-Rad’s BioPlex 2200 System 157
19.5.5 Jul 26, 2010: Bio-Rad Submits Premarket Approval Application To FDA For GS HIV Combo Ag/Ab EIA 157
19.5.6 Jun 30, 2010: Bio-Rad Introduces IH 1000 Blood Screening System 157
19.5.7 May 24, 2010: Bio-Rad Launches BioPlex 2200 MMRV IgG kit 158
19.5.8 Jan 05, 2010: Axis-Shield And Bio-Rad Introduces BioPlex 2200 Anti-CCP Test For Early Detection Of Rheumatoid Arthritis 158
19.5.9 Jun 01, 2009: Bio-Rad Laboratories Announces FDA Approval For ToRC IgG And HSV-1 & HSV-2 IgG Kits 158
19.5.10 Feb 11, 2008: Bio-Rad Launches Vasculitis Kit For Use On The Bioplex 2200 System 159
19.5.11 Nov 13, 2007: Bio-Rad Launches The In2it A1C Analyzer For Point-Of-Care Diabetes Testing 159
19.5.12 Nov 05, 2007: Bio-Rad Introduces Chromogenic Medium In The US For Rapid Screening Of MRSA 159
19.6 Product Approvals 160
19.6.1 Jul 25, 2011: Bio-Rad Receives FDA Premarket Application Approval For GS HIV Combo Ag/Ab EIA 160
19.6.2 Jun 01, 2009: Bio-Rad Laboratories Announces FDA Approval For ToRC IgG And HSV-1 & HSV-2 IgG Kits 160
19.7 Clinical Trials 161
19.7.1 Apr 20, 2011: Researchers Use Bio-Rad’s ProteoMiner Technology To Profile Relative Protein Abundance And Identify Post-Translationally Modified Proteins In Human Saliva 161
19.8 Other Significant Developments 162
19.8.1 Dec 19, 2012: Hospitals, Healthcare Providers To Benefit From New Multi-Source Premier Agreements For Blood Bank Analyzers, Reagents, Consumables And Service 162
20 Appendix 163
20.1 Research Methodology 164
20.2 Secondary Research 164
20.3 Primary Research 164
20.4 Models 165
20.5 Forecasts 165
20.6 Expert Panels 165
20.7 GlobalData Consulting 165
20.8 Currency Conversion 166
20.9 Contact Us 167
20.10 Disclaimer 167
【レポート販売概要】
■ タイトル：Bio-Rad Laboratories, Inc.：市場シェア分析■ 英文：Bio-Rad Laboratories, Inc. Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160480
■ 調査対象地域：グローバル
- 世界のディジタル・オシロスコープ市場About Digital Oscilloscopes An oscilloscope is a testing and measuring equipment that monitors voltage or current passed-to or passed-from an electronic component or device. Initially, an oscilloscope used to function only in the analog mode. Today, through numerous advancements in technology, oscilloscopes are able to operate in a digital mode, and this has led to the deployment of digital oscill …
- データセンター用ラックサーバーの世界市場予測（～2021）：ソリューション、サービス、段タイプ、データセンタータイプThe data center rack server market is estimated to grow from USD 36.47 Billion in 2016 to USD 90.56 Billion by 2021, at a high Compound Annual Growth Rate (CAGR) of 19.95% during the forecast period. Data center rack server solutions are gaining a significant importance among organizations as they are scalable and provide for easy migration from traditional technologies. Rack servers can be instal …
- スマート照明の世界市場：蛍光ランプ、LEDランプ、HIDランプSmart lighting is an advanced technology in lighting that makes use of intelligent lighting control systems to manage the illumination of a particular area. Smart lighting market is growing at a phenomenal rate and main drivers for this growth are energy efficiency, development in electronics and sensor technology, phase out of incandescent lamps, favorable government policies and evolution of nov …
- チアクロプリドの世界市場2015Thiacloprid (CAS 111988-49-9) Market Research Report 2015 aims at providing comprehensive data on Thiacloprid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Thiacloprid description, covers its application areas, manufacturing methods, patterns. It captures Thiacloprid market trends, pays close attention to Thiacloprid manufacturers and names su …
- 食品検査システムの世界市場2015-2022According to Stratistics MRC, the Global Food Diagnostics Systems market is poised to grow at a CAGR of 9.5% during the forecast period. Food Diagnostics has been in market since last couple of years, but rising awareness towards food safety nowadays is acting as a catalyst to market. The advancement in diagnostic technologies for detecting the food contaminants are further driving the market grow …
- ブロノポールの世界市場2016-2020About Bronopol Bronopol (2-bromo-2-nitropropane-1,3-diol) is the common name for the active ingredient in many broad-spectrum antimicrobial agents. It is produced by the bromination of di(hydroxymethyl) nitromethane. Bronopol is used in the treatment of recirculating water systems in industrial applications due to its minimal impact on health and biodegradable properties. Bronopol also acts as a m …
- 水溶性ポリマーの世界市場2019-2023About this market Access to fresh water has emerged as one of the most significant challenges in the face of expanding population worldwide. Consequently, the demand for clean water and wastewater treatment options is rapidly increasing around the world. Water-soluble polymers are used in wastewater treatment, sludge treatment and water purification applications. Water-soluble polymers such as pol …
- 感情検出および認識の世界市場：バイオセンサー、NLP、機械学習、パターン認識、特徴抽出/3DモデリングThe global emotion detection and recognition market is expected to grow from USD 5.66 Billion in 2015 to USD 22.65 Billion by 2020, at a CAGR of 31.9%.Several factors such as rising demand for mapping, especially by the marketing and advertising sector, increasing concerns for security, and growing need for application support during emergency situations has bolstered the growth of emotion detecti …
- 世界の不織布ろ材市場動向（2012-2016）TechNavio’s analysts forecast the Global Nonwoven Filter Media market to reach US$3.88 billion by 2016. One of the key factors contributing to this market growth is the emerging demand from developing countries. The Global Nonwoven Filter Media market has also been witnessing development of next-generation nonwoven filter media. However, regulatory standards and guidelines could pose a challenge t …
- ウィルムス腫瘍 (腎芽細胞腫)：グローバル臨床試験レビューH2, 2013Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013" provides data on the Wilms’ Tumor (Nephroblastoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wilms’ Tumor (Nephroblastoma). It includes an overv …
- 北米の折畳み箱市場2016-2020About Folding Cartons Folding cartons are paperboards that are cut, folded, laminated, and printed for packaging goods. They are available in various sizes and shapes and are often delivered as flat paperboards marked with folding lines to help in packaging. The cartons are made of virgin wood pulp, recycled paper stock, or other fibers. Many new technologies offer aesthetic appeal to these foldin …
- Ultra Petroleum Corp.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- Edison SpA：石油・ガスバリューチェーン分析レポート2013Edison SpA Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Edison SpA" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Edison SpA”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business st …
- レディミックスコンクリートバッチ処理プラントの世界市場：種類別、地域別Global Ready Mix Concrete Batching Plant Market: About this market Technavio’s ready mix concrete batching plant market analysis considers sales from dry batch concrete plant and wet batch concrete plant types. Our study also finds the sales of ready mix concrete batching plants in APAC, Europe, MEA, North America, and South America. In 2019, the dry batch concrete plant segment had a significant …
- 世界のスマートグリッド分析：Analyzing the Global Smart GridSmart Grids are electrical grids which use information and communications technology to gather and act on information, such as information about the behaviors of suppliers and consumers, in an automated fashion to improve the efficiency, reliability, economics, and sustainability of the production and distribution of electricity. For a century, utility companies have had to send workers out to gat …
